News Releases

A empresa aumentou a capacidade de produção para fornecer 30 milhões de testes por mês O teste serológico deteta anticorpos IgG que visam o domínio de ligação do recetor da proteína...

Beckman Coulter ha aumentato la capacità produttiva per raggiungere la disponibilità di 30 milioni di test al mese Il test sierologico rileva gli anticorpi IgG che riconoscono il...

Das Unternehmen hat die Produktionskapazität zur Auslieferung von monatlich mehr als 30 Millionen Tests erhöht. Dieser serologische Test weist gegen die Rezeptor-bindende Domäne des...

L'entreprise a augmenté sa capacité de production pour fournir 30 millions de tests par mois Le test sérologique détecte les anticorps IgG dirigés contre le domaine de liaison au récepteur...

Brea, Calif, June 15, 2020 — Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more...

Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T...

Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to...

Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans...

In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be...

Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...